Publications by authors named "Evis Harja"

Claim this Profile
R
Regulation of Receptor for Advanced Glycation End Products (RAGE) Ectodomain Shedding and Its Role in Cell Function.
Alex Braley, Taekyoung Kwak, Joel Jules, Evis Harja, Ralf Landgraf

J Biol Chem· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
(
(124)I PET/CT in Patients with Differentiated Thyroid Cancer: Clinical and Quantitative Image Analysis.
Seza A Gulec, Russ A Kuker, Mohammed Goryawala, Carlos Fernandez, Rudolfo Perez, Evis Harja

Thyroid· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An analysis of characteristics of subjects examined for incretin effects on pancreatic pathology.
Evis Harja, Jonathan Lord, Jay S Skyler

Diabetes Technol Ther· August 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive monitoring the biology of atherosclerotic plaque development with radiolabeled annexin V and matrix metalloproteinase inhibitor in spontaneous atherosclerotic mice.
Yared Tekabe, Qing Li, Joane Luma, Drew Weisenberger, Marija Sedlar, Evis Harja

J Nucl Cardiol· December 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Alternatively spliced RAGEv1 inhibits tumorigenesis through suppression of JNK signaling.
Anastasia Z Kalea, Fiona See, Evis Harja, Maria Arriero, Ann Marie Schmidt

Cancer Res· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mice deficient in PKCbeta and apolipoprotein E display decreased atherosclerosis.
Evis Harja, Jong Sun Chang, Yan Lu, Michael Leitges, Yu Shan Zou

FASEB J· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A clinical comparison of slow- and rapid-escalation treprostinil dosing regimens in patients with pulmonary hypertension.
Nika Skoro-Sajer, Irene M Lang, Evis Harja, Meinhard P Kneussl, Wendy Gin Sing

Clin Pharmacokinet· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Interaction of the RAGE cytoplasmic domain with diaphanous-1 is required for ligand-stimulated cellular migration through activation of Rac1 and Cdc42.
Barry I Hudson, Anastasia Z Kalea, Maria Del Mar Arriero, Evis Harja, Eric Boulanger

J Biol Chem· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification, classification, and expression of RAGE gene splice variants.
Barry I Hudson, Angela M Carter, Evis Harja, Anastasia Z Kalea, Maria Arriero

FASEB J· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vascular and inflammatory stresses mediate atherosclerosis via RAGE and its ligands in apoE-/- mice.
Evis Harja, De-xiu Bu, Barry I Hudson, Jong Sun Chang, Xiaoping Shen

J Clin Invest· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Infection with a periodontal pathogen increases mononuclear cell adhesion to human aortic endothelial cells.
Georg A Roth, Bernhard Moser, Franziska Roth-Walter, Mary Beth Giacona, Evis Harja

Atherosclerosis· February 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protein kinase C beta/early growth response-1 pathway: a key player in ischemia, atherosclerosis, and restenosis.
Shi-Fang Yan, Evis Harja, Martin Andrassy, Tomoyuki Fujita, Ann Marie Schmidt

J Am Coll Cardiol· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
RAGE modulates vascular inflammation and atherosclerosis in a murine model of type 2 diabetes.
Thoralf Wendt, Evis Harja, Loredana Bucciarelli, Wu Qu, Yan Lu

Atherosclerosis· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Receptor for advanced-glycation end products: key modulator of myocardial ischemic injury.
Loredana G Bucciarelli, Michiyo Kaneko, Radha Ananthakrishnan, Evis Harja, Larisse K Lee

Circulation· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The RAGE Gly82Ser polymorphism is not associated with cardiovascular disease in the Framingham offspring study.
Marion A Hofmann, Qiong Yang, Evis Harja, Prashant Kedia, Peter K Gregersen

Atherosclerosis· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Soluble levels of receptor for advanced glycation endproducts (sRAGE) and coronary artery disease: the next C-reactive protein?
Barry I Hudson, Evis Harja, Bernhard Moser, Ann Marie Schmidt

Arterioscler Thromb Vasc Biol· May 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Central role of PKCbeta in neointimal expansion triggered by acute arterial injury.
Martin Andrassy, Dmitry Belov, Evis Harja, Yu Shan Zou, Michael Leitges

Circ Res· March 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early growth response-1 promotes atherogenesis: mice deficient in early growth response-1 and apolipoprotein E display decreased atherosclerosis and vascular inflammation.
Evis Harja, Loredana G Bucciarelli, Yan Lu, David M Stern, Yu Shan Zou

Circ Res· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis